Agents in the 2nd Line Setting in RCC
Nancy A. Dawson MD, Professor of Medicine at Lombardi Cancer Center elaborates on the preferred agents on the 2nd line setting of renal cell carcinoma if a patient progresses on pembrolizumab/axitinib...
Author: obr
Added: 06/26/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts